An 18-year-old girl presents with episodic breathlessness, cough with sputum, chest tightness and wheezing for the last 4 years. She also complains of recurrent sneezing and nasal blockage. Discuss the evaluation and management of this patient.
25 marks · directive: Discuss
The core of a good answer
The history points to bronchial asthma with allergic rhinitis; evaluation confirms variable airflow obstruction by spirometry with bronchodilator response or peak flow variability, looks for atopy and triggers, and management treats both upper and lower airway: inhaled corticosteroid-based therapy stepped up or down to control, intranasal corticosteroids, trigger avoidance, inhaler technique, an action plan and, where indicated, allergen immunotherapy or biologics.
An outline written by upsc.help, not an official UPSC answer; every fact checked by a separate review. How we work
What the question asks
For 25 marks the examiner expects a full clinical approach: history, examination, investigations with interpretation, differential diagnosis, stepwise long-term management, management of exacerbations, and the link between rhinitis and asthma.
Answer outline
Introduction
Asthma is a common long-term inflammatory disease of the airways with variable and recurring symptoms. Allergic rhinitis often coexists with it; with eczema (atopic dermatitis) they form the atopic triad.
History
- Pattern: episodic, nocturnal or early-morning symptoms; triggers (dust mites, pollen, cigarette smoke, cold air, exercise, viral infections, aspirin and other NSAIDs, beta-blockers).
- Rhinitis: sneezing, runny or stuffy nose, itchy watery eyes; personal or family history of atopy and eczema.
- Severity: night waking, reliever use, activity limitation, past emergency visits and steroid courses; home and occupational exposures; smoking.
Examination
- Wheeze, prolonged expiration; allergic shiners; pale, boggy inferior turbinates.
Investigations
- Spirometry, the most accurate measure of lung function, with bronchodilator response; peak flow variability (daily changes above 10% may suggest asthma) or bronchial provocation with methacholine.
- FeNO, blood eosinophils, IgE, skin prick tests or allergen-specific IgE.
- Chest X-ray to exclude other causes.
Differential diagnosis
- Vocal cord dysfunction, bronchiectasis, gastro-oesophageal reflux, foreign body aspiration.
Long-term management of asthma
- Updated guidelines prefer inhaled corticosteroid (ICS) treatment over short-acting beta2 agonist (SABA) alone; combined ICS with a long-acting beta2 agonist (LABA) is first-line for teenagers and adults.
- If uncontrolled, add a leukotriene receptor antagonist (montelukast) or tiotropium, or refer for biologic therapy in severe disease.
- Check adherence, inhaler technique and triggers before stepping up; step down after two to three months of good control.
- Written asthma action plan; avoid smoke and other triggers.
Management of allergic rhinitis
- Intranasal corticosteroids are the preferred treatment for persistent symptoms; antihistamines, montelukast and saline irrigation help.
- Allergen immunotherapy (subcutaneous, or sublingual tablets or drops), given for three to five years, is the only treatment that alters the disease mechanism.
Acute exacerbation
- Inhaled salbutamol (with ipratropium), oral corticosteroids and oxygen; IV magnesium sulfate only for patients who do not respond to first-line treatment.
Conclusion
Confirming the diagnosis objectively and treating the upper and lower airway together with ICS-based therapy, nasal steroids and education gives good control in most young patients.
Facts to remember
- Asthma diagnosis rests on symptom pattern, response to treatment and lung function tests; spirometry is the most accurate measure of lung function.
- Daily peak flow changes greater than 10% may suggest asthma.
- Updated guidelines prefer ICS over SABA-only treatment; teens and adults are recommended combined ICS and LABA.
- Intranasal corticosteroids are the preferred medication for persistent allergic rhinitis.
- Allergen immunotherapy is typically given for three to five years and is the only treatment that alters the disease mechanism.